Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I

Documenti analoghi

• Editorial: Pharmacological and Biochemical Perspectives of Kinase Inhibitors in Cancer and COVID-19 Therapeutics, Volume I
  di: Balakumar Chandrasekaran, et al.
  Pubblicazione: (2022-06-01)
• Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
  di: Nem Kumar Jain, et al.
  Pubblicazione: (2023-03-01)
• Kinase Targeted Anticancer Agents: A Perspective
  di: Shannelle Diana Habániková, et al.
  Pubblicazione: (2022-08-01)
• The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
  di: Eric Toussirot
  Pubblicazione: (2022-02-01)
• Exploring the role of Janus kinase (JAK) in atopic dermatitis: a review of molecular mechanisms and therapeutic strategies
  di: Toshiaki Kogame, et al.
  Pubblicazione: (2023-07-01)